FDA Drug · D-0041-2027

Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.

Class II · Ongoing

Lack of process control

Affected lots / codes — check yours against thisLot# SER-081726-1-10, Beyond Use Date: 10/01/2026.

Recalling firm: Houston Rx LLC, Houston, TX
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 7 vials
Distribution: Nationwide in the USA.
Recall initiated: September 25, 2026
Classified: October 13, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0041-2027%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →